Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DehydraTECH-darunavir
- Development stage
- Preclinical
- Lead developer
- Lexaria Bioscience
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
DehydraTECH-darunavir is an investigational oral formulation of the HIV-1 protease inhibitor darunavir, utilizing Lexaria Bioscience's proprietary DehydraTECH drug delivery technology. Developed by Cannabis Delivery Sciences, a subsidiary of Lexaria Bioscience, this formulation is designed to enhance the bioavailability and intestinal absorption of darunavir, a small molecule typically used in combination with a pharmacokinetic enhancer (like ritonavir or cobicistat) to treat HIV infection. By improving the delivery profile, DehydraTECH-darunavir aims to potentially reduce the required dosage and the need for boosting agents, thereby minimizing side effects and improving patient adherence. The program is currently in the preclinical stage of development for the treatment of HIV.
- Other names
- darunavir (DehydraTECH formulation)DehydraTECH-processed darunavir
02
Targets
PR (Progesterone receptor)
Beyond the preview
Go deeper on DehydraTECH-darunavir.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DehydraTECH-darunavir.